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Background: Long-acting reversible contraceptives (LARCs) are associatedwith high efficacy rates and continuity
of use. Based on the foregoing, we sought to examine the prevalence and factors associated with LARC use
among sexually active women in 26 countries in sub-Saharan Africa(SSA).
Methods: Secondary data from Demographic and Health Surveys conducted in 26 countries in SSA between
January 2010 and December 2019 were pooled and analysed. A total of 56 067 sexually active women 15–49 y
of age met the inclusion criteria. Bivariate and multivariate regression analyses were performed to examine the
association between selected factors and the use of LARCs in SSA. Results were presented as crude odds ratios
and adjusted odds ratios (aORs) with statistical precision at <0.05.
Results: The prevalence of LARC use was 21.73%, ranging from 1.94% in Namibia to 54.96% in Benin. Sexually
active women with secondary or higher education (aOR 1.19 [95% confidence interval {CI} 1.08 to 1.32]), those
cohabiting (aOR 1.25 [95%CI 1.06 to 1.47]) and thosewith four ormore children (aOR 2.22 [95%CI 1.78 to 2.78])
were more likely to use LARCs compared with those without education, never married and with no biological
child.
Conclusions: The use of LARCs in the 26 countries in SSA was relatively low. Hence, the identified contributory
factors of LARC use should be tackled with appropriate interventions. These include continuous campaigns on
the efficacy of LARCs in reducing unintended pregnancy, maternal mortality and morbidity.
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Introduction
Globally, there have been significant efforts to reduce unintended
pregnancies and fertility rates.1,2 One such effort has been the
campaign for the use of modern contraceptives among sexually
activewomen.3 Available evidence shows that these actions have
effectively increased contraceptive use among sexually active
women.4 However, most sexually active women who use mod-
ern contraceptives use short-term methods such as oral contra-
ceptive pills and condoms, which have been identified as being
significantly associated with high rates of discontinuation.5–7 This
situation has persisted at the expense of long-acting reversible
contraceptives (LARCs).
LARCsmaybe viewedas hormonal and copper intrauterine de-
vices and contraceptive implants.8 Globally notmore than 15%of
women use LARCs.9 Europe, for instance, has a varied prevalence
of LARC use; the prevalence of LARC use in Poland is 2.9%, while
France has a prevalence of about 16%, which is higher than the
global proportion of women using LARCs.10 Other regions, such as
Latin America and Asia, have recorded a high prevalence of LARC
use.11,12 However, in sub-Saharan Africa (SSA), the prevalence of
LARC use among women is <3%.13
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LARCs are known to have fewer contraindications and are
without age restrictions.14 Moreover, they are cost effective and
highly efficacious in preventing unintended pregnancy.15–17 Given
that LARC use is independent of user compliance, they are more
efficacious, with an annual pregnancy rate of <1% for women
using LARCs compared with their counterparts who rely on short-
term contraceptives such as oral pills and condoms, which have
annual pregnancy rates of 9% and 18%, respectively.8 Thus
LARCs are a more efficacious choice.
Nevertheless, the availability and use of LARCs remains
low among sexually active women, especially those living in
SSA.1,13,18 Studies show that there may be some potential ad-
verse health concerns with the use of LARCs, which serves as
a disincentive for many women to accept and utilize them.19
LARCs are associated with multiple adverse health events, in-
cluding distortion of menstrual bleeding (either heavy or less
than usual bleeding), an increase in the risk of iron deficiency
anaemia and pelvic pain.19–21 Other factors such as the availabil-
ity of LARCs, misconceptions about their use and the perceived
cost are some of the barriers to the use of LARCs.22 This raises
concerns about how demographic (age, place of residence, etc.)
and socio-economic factors (such as wealth quintile, educational
level, media exposure) affect LARC use among sexually active
women.
Given the importance of LARCs in ensuring high efficacy rates
and contraceptive continuation,23 the need to understand the
factors that predict their use among sexually active women
has become paramount to the realization of better reproductive
health outcomes and higher uptake of LARCs. Despite this ur-
gency for a better understanding of the predictors of LARCs, it
has received little attention in SSA. Therefore, we sought to bridge
this literature gap by examining the prevalence and predictors of
LARC use among sexually active women in SSA using the most
recent Demographic and Health Survey (DHS) data from 26 coun-
tries. We hope this study’s findings will be a contributing catalyst
to Africa’s efforts to reducematernalmortality andmorbidity and
significantly reduce unintendedpregnancies linked to Sustainable
Development Goal 3 by increasing the coverage and use of LARCs.
Methods
Data source and study design
Data utilized in this studywere pooled fromDHSs conducted in 26
countries in SSA between 2010 and 2019. The countries, years the
surveywas conducted and sample size for each country are listed
in Table 1. The DHS dataset is a nationally representative survey
conducted in about 85 low- and-middle-income countries with
a core target of sexual and reproductive health issues, including
contraceptive use.24 The women’s files, which contain informa-
tion on women of reproductive age, were used for this study.
The DHS employed stratified two-stage sampling techniques
to ensure national representativeness.25 The first stage was the
development of a sampling frame containing a list of primary
sampling units (PSUs), also known as enumeration areas (EAs),
which cover each participating country’s entirety. The PSUs are
obtained from the latest available national census. Each PSU is
further subdivided into standard size segments of about 100–500
households per segment. Random selection of predetermined
sample segments is done afterward with probability proportional
to the EA’s measure of size depending on the number of house-
holds in each EA.
The second stage entails the systematic selection of house-
holds from the list of households previously enumerated by DHS
personnel.Women 15–49 y of age andmen 15–64 y of agewithin
the selected households are then interviewed. The countries in-
cluded in the present study had their surveys conducted at dif-
ferent times due to variations in the starting points of DHS data
collection in these countries. Nomads and persons in institutional
groups, such as prisoners and hotel occupants, are usually ex-
cluded from the sample frame. The use of multiple DHS datasets
from SSA countries has been previously achieved in other stud-
ies.26,27 Despite the variation in starting points of surveys in vari-
ous countries, we compared the DHSs among the countries. Per-
mission to utilize the 26 SSA datasetswas sought fromMonitoring
and Evaluation to Assess and Use Results (MEASURE) DHS and the
datasets are freely available publicly at https://dhsprogram.com/
data/available-datasets.cfm.
Sample size and inclusion criteria
A total of 56 067women 15–49 y of agewhowere sexually active
(those who had ever had sex) and were usingmodern contracep-
tives at the time of the surveys were included in our study; a to-
tal of 26 SSA countries were included in the final analysis. These
records were used for the analysis because they had complete
sets of all the variables of interest in the current study.
Definition of study variables
Outcome variable
The study’s outcome variable was ‘LARC,’ which arose from the
question about the type of contraceptive women 15–49 y of age
who were sexually active were using at the time of the sur-
vey. Women who were using modern contraceptives such as
condoms, pills, injections, female sterilization, vasectomy, emer-
gency contraceptives and othermethodswere categorized as not
using LARC, while those using an intrauterine device (IUD) or im-
plant were categorized as using LARC.13,28 Those using methods
other thanmodern contraceptives were excluded from the study.
Explanatory variables
Nine explanatory variables were considered in this study, includ-
ing age, place of residence, education level, marital status, cur-
rently working, wealth index, parity, media exposure and the
desire for more children. These variables have been reported
to predict LARC use in previous nationally representative stud-
ies.28–30 Four of the explanatory variables were recoded for bet-
ter analysis outputs and interpretation. The age of respondents
was recoded as 15–24 (0), 25–34 (1) and ≥35 (2). Marital sta-
tus was recoded into never married (0), married (1), cohabiting
(2) and ever married (3). We recoded parity (children ever born)
as zero births (0), one to three births (1) and four or more births
(2). Finally, exposure to mass media was recoded into no (0) for












Table 1. Sample size distribution by country and survey year
Survey countries Survey year Weighted sample Weighted percentage
Central Africa
Democratic Republic of Congo 2014 1034 1.84
Cameroon 2019 1476 2.63
Chad 2015 497 0.89
Malawi 2016 1327 2.37
Rwanda 2015 3190 5.69
West Africa
Burkina Faso 2010 1878 3.35
Benin 2018 1241 2.21
Gambia 2013 457 0.82
Guinea 2018 602 1.07
Liberia 2013 1374 2.45
Nigeria 2018 3100 5.53
Niger 2012 753 1.34
Mali 2018 1327 2.37
Sierra Leone 2013 2473 4.41
Senegal 2018 1267 2.26
Togo 2014 1075 1.92
Ghana 2014 1133 2.02
East Africa
Kenya 2014 4405 7.86
Ethiopia 2016 1132 5.92
Tanzania 2016 2738 4.88
Uganda 2011 3639 6.49
Southern Africa
Comoros 2012 380 0.68
Lesotho 2014 1774 3.16
Namibia 2013 2337 4.17
South Africa 2016 2484 4.43
Zimbabwe 2018 3720 6.63
Source: DHS from 26 SSA countries: 2010–2019.
television and yes (1) for those who read the newspaper, listen to
the radio or watch television at least once a week.
Statistical analyses
The analysis beganwith the computation of LARCuse among sex-
ually active women of reproductive age in 26 countries in SSA.We
then appended the dataset from the countries, generating a to-
tal sample of 56 067. We calculated the overall prevalence, pro-
portions of LARC use and chi-square values across the selected
sociodemographic characteristics after appending. Binary logistic
regression analysis was performed in twomodels: the first model
(model 1) was a bivariate analysis of the country effect on LARC
use. The reference country was Angola, due to the limited con-
traceptive use that has been reported in that country.31 Model
2 adjusted for the effects of the other explanatory variables to
ascertain how these variables influence LARC use. The choice
of reference categories for the explanatory variables was deter-
mined by similar previous studies.30,32 Binary logistic regression
modelling was employed because our dependent variable (LARC
use) was measured as a binary factor. We presented the regres-
sion analysis results as crude odds ratios (cORs) and adjusted
odds ratio (aORs), with their corresponding 95% confidence inter-
vals (CIs) signifying the precision and significance of the reported
OR. The multicollinearity test, which used the variance inflation
factor (VIF), revealed no collinearity among the independent vari-
ables employed in this study (mean VIF 1.44, maximum VIF 1.96
and minimum VIF 1.06). The inherent survey sample weight to
control for undersampling and non-responses was applied. All
analyses were carried out with Stata version 16.0 (StataCorp, Col-
lege Station, TX, USA).
Results
Descriptive results
Figure 1 presents the prevalence of LARC use in each of the 26
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Percentage of LARC use
Figure 1. Prevalence of LARC use in SSA among sexually active women.
ranged from 1.94% in Namibia to 54.96% in Benin. Overall, the
prevalence of LARC use among sexually active women in the 26
SSA countries was 21.73%.
Table 2 shows results of the distribution of sexually active
women currently usingmodern contraceptives in SSA by explana-
tory variable. The results show a high prevalence of LARC use
among sexually active women ages 25–34 y (23.74%), those re-
siding in a rural area (37.91%), thosewith no education (26.90%),
ever married sexually active women (24.14%), women currently
employed (23.13%), those within the richest wealth index quin-
tile (23.45%), those with four or more children (24.91%), sexually
active women not exposed to mass media (22.00%) and those
who were undecided if they desire more children (26.15%). All
selected explanatory variables were significant at 0.001, except
the place of residence and mass media exposure, with p-values
>0.05.
Association between selected explanatory variables
and LARC use among sexually active women in SSA
Two models were fitted to examine the association between
selected explanatory variables and LARC use, with the re-
sults presented in Table 3. Model 1 was a crude model that
was unadjusted and model 2 adjusted for the confounders.
In model 2, a statistically significant effect of LARC use was













Table 2. Distribution of sexually active women using LARCs by explanatory variables in SSA (N=56 067)
Using LARCs, n (%)
Variables Weighted Frequency (n) Weighted Percentage No Yes p-Value (χ2)
Age (years) <0.001
15–24 13 961 24.90 10 937 (81.80) 2433 (18.20)
25–34 24 092 42.97 17 595 (76.26) 5478 (23.74)
35–49 18 015 32.13 13 494 (78.21) 3759 (21.79)
Place of residence 0.98
Urban 23 312 41.58 17 476 (78.28) 4850 (21.72)
Rural 32 755 58.42 24 550 (78.26) 6820 (21.74)
Education level <0.001
No education 11 015 77.68 7712 (73.10) 2838 (26.90)
Primary 21 685 22.32 16 365 (78.80) 4403 (21.20)
Secondary/higher 23 367 17 950 (80.21) 4428 (19.79)
Marital status <0.001
Never married 6567 11.71 5566 (88.51) 722 (11.49)
Married 39 725 70.85 28 860 (75.86) 9185 (24.14)
Cohabiting 7653 13.65 5942 (81.08) 1386 (18.49)
Ever married 2123 3.79 1657 (81.51) 375 (21.73)
Currently working <0.001
No 18 381 32.78 14 281 (81.12) 3323 (18.88)
Yes 37 686 67.22 27 746 (76.87) 8347 (23.13)
Wealth index <0.001
Poorest 6916 12.34 5226 (78.90) 1398 (21.10)
Poorer 9415 16.79 7186 (79.69) 1831 (20.31)
Middle 10 531 18.78 7935 (78.67) 2151 (21.33)
Richer 13 163 23.48 9919 (78.68) 2688 (21.32)
Richest 16 042 28.61 11 761(76.55) 3602 (23.45)
Parity <0.001
No children 4448 7.93 3782 (88.78) 478 (11.22)
1–3 children 29 039 51.79 22 004 (79.12) 5806 (20.88)
≥4 children 22 581 40.27 16 240 (75.09) 5386 (24.91)
Media exposure 0.57
No 11 644 20.77 8698 (78.00) 2453 (22.00)
Yes 44 424 79.23 33 328 (78.34) 9217 (21.66)
Desire for more children <0.001
Want more 30 632 54.63 23 119 (78.80) 6218 (21.20)
Undecided 2068 3.69 1462 (73.85) 518 (26.15)
No desire 23 367 41.68 17 445 (77.95) 4934 (22.05)
The likelihood of using LARCs was higher among sexually ac-
tivewomenwith a secondary or higher education (aOR 1.19 [95%
CI 1.08 to 1.32]), those who weremarried (aOR 1.38 [95% CI 1.17
to 1.63]), those cohabiting (aOR 1.25 (95% CI 1.06 to 1.47]), sex-
ually active women with one to three children (aOR 1.94 [95%
CI 1.58 to 2.38]) and those with four or more children (aOR 2.22
[95% CI 1.78 to 2.78]) compared with those without education,
those evermarried and thosewith no children, respectively, while
those ≥35 y of age were less like to use LARCs (aOR 0.85 [95% CI
0.77 to 0.95]).
SSA countries with lower odds of using LARCs in the adjusted
model (model 2) included Chad (aOR 0.36 [95% CI 0.24 to 0.54]),
Benin (aOR 0.35 [95% CI 0.23 to 0.54]), Nigeria (aOR 0.49 [95%
CI 0.35 to 0.70]), Ghana (aOR 0.07 [95% CI 0.05 to 0.11]) and
South Africa (aOR 0.34 [95% CI 0.26 to 0.44]), while sexually ac-
tive women in Cameroon (aOR 4.30 [95% CI 3.55 to 5.19]) had
higher odds of using LARCs than any other SSA countries (see
Table 3).
Discussion
LARCs may help alleviate the high unmet need for modern con-
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Table 3. Bivariate and multivariable models showing the relationship between LARC use and selected explanatory variables among sexually
active women in SSA countries
Model 1 (unadjusted) Model 2 (adjusted)
Variables cOR 95% CI aOR 95% CI
Age (years)
15–24 Ref Ref
25–34 1.40*** 1.31–1.50 1.08 1.00 to 1.17
≥35 1.25*** 1.16 to 1.35 0.85** 0.77 to 0.95
Place of residence
Urban Ref Ref
Rural 1.00 0.94 to 1.07 0.93 0.85 to 1.01
Education level
No education Ref Ref
Primary 0.73*** 0.68 to 0.79 1.02 0.94 to 1.11
Secondary/higher 0.67*** 0.62 to 0.73 1.19*** 1.08 to 1.32
Marital status
Never married Ref Ref
Married 2.45*** 2.20 to 2.73 1.38*** 1.17 to 1.63
Cohabiting 1.80*** 1.59 to 2.03 1.25** 1.06 to 1.47
Ever married 1.75*** 1.48 to 2.07 1.18 0.97 to 1.44
Currently working
No Ref Ref
Yes 1.29*** 1.22 to 1.37 1.06 1.00 to 1.13
Wealth index
Poorest Ref Ref
Poorer 0.95 0.87 to 1.04 0.93 0.85 to 1.01
Middle 1.01 0.92 to 1.11 0.96 0.88 to 1.06
Richer 1.01 0.92 to 1.11 0.95 0.85 to 1.04
Richest 1.15** 1.04 to 1.26 1.03 0.92 to 1.16
Parity
No children Ref Ref
1–3 children 2.09*** 1.80 to 2.42 1.94*** 1.58 to 2.38
≥4 children 2.63*** 2.27 to 3.04 2.22*** 1.78 to 2.78
Media exposure
No Ref Ref
Yes 0.98 0.92 to 1.05 1.03 0.96 to 1.11
Desire for more children
Want more Ref Ref
Undecided 1.32*** 1.15 to 1.51 1.21** 1.05 to 1.39
No desire 1.05 0.99 to 1.11 1.12** 1.05 to 1.21
Country
Democratic Republic of Congo Ref Ref
Cameroon 4.18*** 3.47 to 5.04 4.30*** 3.55 to 5.19
Chad 0.37*** 0.24 to 0.55 0.36*** 0.24 to 0.54
Malawi 0.78* 0.64 to 0.95 0.81* 0.66 to 0.99
Rwanda 1.29* 1.05 to 1.59 1.31* 1.06 to 1.62
Burkina Faso 1.13 0.90 to 1.43 1.11 0.87 to 1.41
Benin 0.40*** 0.25 to 0.62 0.35*** 0.23 to 0.54
Gambia 1.60*** 1.26 to 2.04 2.02*** 1.55 to 2.63
Guinea 1.12 0.95 to 1.32 1.02 0.86 to 1.21
Liberia 0.49** 0.32 to 0.74 0.48** 0.32 to 0.73
Nigeria 0.45*** 0.32 to 0.64 0.49*** 0.35 to 0.70
Niger 0.17*** 0.13 to 0.23 0.16*** 0.12 to 0.22
Mali 3.23*** 2.62 to 3.98 3.15*** 2.55 to 3.88
Sierra Leone 0.96 0.82 to 1.12 0.90 0.76 to 1.05













Model 1 (unadjusted) Model 2 (adjusted)
Variables cOR 95% CI aOR 95% CI
Togo 0.16*** 0.11 to 0.24 0.15*** 0.10 to 0.23
Ghana 0.07*** 0.05 to 0.99 0.07*** 0.05 to 0.11
Kenya 0.79** 0.67 to 0.93 0.77** 0.65 to 0.91
Ethiopia 0.89 0.74 to 1.07 1.05 0.87 to 1.28
Tanzania 2.69*** 2.08 to 3.47 2.57*** 1.98 to 3.33
Uganda 1.22 0.88 to 1.71 1.18 0.84 to 1.65
Comoros 1.16 0.92 to 1.45 1.21 0.96 to 1.52
Lesotho 1.02 0.85 to 1.23 1.02 0.84 to 1.24
Namibia 0.99 0.84 to 1.16 0.95 0.80 to 1.13
South Africa 0.33*** 0.26 to 0.42 0.34*** 0.26 to 0.44
Zimbabwe 0.64*** 0.54 to 0.76 0.56*** 0.47 to 0.68
Pseudo-R2 0.0772
Model 1: unadjusted model examining the association of selected factors and LARC use. Model 2: adjusted for confounders. Exponentiated
coefficients. cOR, Crude Odds Ratio; AOR, Adjusted Odds Ratio; CI, Confidence Interval.
Ref: reference.
*p<0.05, **p <0.01, ***p<0.001.
and not reliant on user compliance.33,34 Yet empirical evidence
on this is sparse in SSA. This study examined the prevalence and
predictors of LARC use among sexually active women usingmod-
ern contraceptives in 26 SSA countries. The prevalence of LARC
use ranged from 4.50% in Niger to 54.96% in Benin and over-
all the prevalence of LARC use among sexually active women in
the 26 SSA countries was 21.73%. This result is higher than in a
study conducted among women in SSA that reported LARC use
of <3%.13
Our study found that the likelihood of using LARCs was higher
among sexually active women with secondary or higher edu-
cation compared with those without education. This is because
most educated women have increased access to information on
the side effects and benefits of using LARC methods.35 As such,
they are aware of themisconceptions andmyths that often serve
as a deterrent to the use of LARCs. Studies conducted in Kenya,34
Ethiopia35,36 and Uganda37 have shown that higher education is
an important predictor of LARC use.
This study showed that the prevalence of contraceptive use
was higher among sexually active women who were married
compared with those who were ever married. This finding is sup-
ported by several studies that have demonstrated a positive cor-
relation between marriage and modern contraceptive use.38,39
However, this contradicts a study conducted in the Democratic
Republic of Congo that reported that modern methods and LARC
use were lower among married women.40 This could be related
to family or social pressure to give birth quickly after marriage.40
Therefore there is a need to introduce contraception use among
sexually active women during antenatal care visits to encourage
child spacing and delay subsequent pregnancy.
In this study, sexually active women cohabiting with their
partners were more likely to use LARCs. This could be to avoid
being exposed to unintended pregnancy, thus leaving them with
no choice but to have a positive attitude towards LARC meth-
ods.41 The study also showed that sexually active women with
one to three children and those with four or more children
had a similar likelihood of using LARCs compared with those
with no children. As the number of children increased, the like-
lihood of using LARCs also increased.42 A possible explanation
for this finding could be that multiparous women tend to re-
ceive family planning education and counselling on contraceptive
use throughout their pregnancy cycle, thereby increasing their
odds of using LARCs.42 This corroborates findings fromother stud-
ies where marital status and parity have been identified as im-
portant individual characteristics influencing women’s reproduc-
tive health behaviours, including demand and uptake of modern
contraception.43–45
Also, sexually active women who were ≥35 y of age were less
likely to use LARCs compared with younger women. This is con-
trary to a study conducted in Kenya that showed more LARC us-
age among those ages 20–24 y.46 Increasing LARC usage in SSA
countries will require continuous community awareness cam-
paigns to counteract negative perceptions andmisinformation.47
Our study revealed that sexually activewomen from some SSA
countries such as Chad, Benin, Nigeria, Ghana and South Africa
had lower odds of using LARCs, while women in Cameroon had
higher odds of using LARCs than in any other SSA countries. This
may be because there are programmes in place that encourage
LARC uptake and this is more markedly documented among sex-
ually active women in Cameroon.48
The positive efforts of the Cameroon government and family
planning providers to increasemodern contraceptive practice has
ensured higher usage of LARCs.49 The findings of this study will
help policymakers, governments and family planning providers to
inform policy regarding the benefits of using LARCs and address
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Strengths and limitations
The large sample size from countries in SSA is the major strength
of this study, making the findings applicable to sexually active
women in SSA. A limitation of this study is that it is a cross-
sectional survey, so the progressive order of contraceptive use.
The study employed a cross-sectional design, therefore, we could
onlymeasure associative effects but not causal effect. The differ-
ent interventions recommended in this study may not be appli-
cable in all countries in SSA, as economic, cultural and social dif-
ferences between SSA countries may influence LARC usage. Fur-
thermore, this study analysis did not consider the effects of ac-
cessibility to LARCs and women’s beliefs related to LARC use.
Policy implications for SSA countries
The findings of this study hold some policy implications for coun-
tries in SSA. Generally, women with a secondary or higher ed-
ucation were more likely to use LARCs, which shows the need
to target women without education and enlighten them on the
benefits of LARCs use. Family planning providers need to counsel
womenwithout children concerning their fears about side effects
andmisconceptions of LARCs and emphasize that LARCmethods
are reversible.
Conclusions
We found that the use of LARCs in the 26 countries in SSA consid-
ered in this study is relatively low. There is a need for sexually ac-
tive women in SSA to receive counselling on the benefits of using
LARCs. Furthermore, governments, policymakers and stakehold-
ers should create awareness by implementing health promotion
strategies to increase the need for LARC usage among sexually
active women in SSA. Implementation of educational campaigns
for sexually active women with lower education should be pri-
oritized in SSA countries. Also, intervention programmes such as
campaigns on the efficacy of LARCs in reducing unintended preg-
nancy and maternal mortality and morbidity should be encour-
aged among sexually active women with low LARC use.
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